Back

The Dutch Cardio-Oncology cohort: Incidence of cardiovascular disease predisposes to a higher cancer mortality rate.

26 August 2023 (16:15 - 16:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk in patients with cancer Cardio-Oncology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Assistant Professor Yvonne Koop

University Medical Center Utrecht, Utrecht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Association between fasting glucose and cardiovascular disease mortality in cancer survivors: a population-based study
Doctor M. Jung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Anti-diabetic medication adherence and cardiovascular outcomes in patients with cancer: a nationwide population-based cohort study
Doctor M. Jung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Clinical application of the HFA/ICOS score in breast cancer women: its added value in the prediction of chemotherapy-related cardiac dysfunction
Associate Professor G. Novo (Palermo, IT)
Abstract Slides Video
Presentation thumbnail
Is staging for cardiac damage in aortic stenosis associated with MACE in cancer patients with prior radiotherapy or chemotherapy that underwent transcatheter aortic valve replacement?
Doctor S. Santos Patarroyo (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Cardiac CARE study: How the ESC Cardio-Oncology guidelines fo 2022 affect the study population
Doctor K. Loganath (Southampton, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk in patients with cancer

The Event

Event poster

ESC Congress 2023

26 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization
thumbnail
Congress Presentation
Mode of death in patients with heart failure: how trends of cardiovascular mortality and death due to cancer changed in the last 25 years.
thumbnail
Congress Presentation
Impact of cancer history on non-ST-segment elevation myocardial infarction (NSTEMI) prognosis, a propensity-score matching (PSM) analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources